Titre : | Groin tissue necrosis requiring skin graft following parental abuse of buprenorphine tablets (2003) |
Titre traduit : | (Nécrose tissulaire de l'aine nécessitant une greffe de peau consécutive à l'injection parentérale de comprimés de buprénorphine) |
Auteurs : | G. F. X. FEENEY ; P. FAIRWEATHER |
Type de document : | Article : Périodique |
Dans : | Drug and Alcohol Review (Vol.22, n°3, September 2003) |
Article en page(s) : | 359-361 |
Langues: | Anglais |
Discipline : | PAT (Pathologie organique / Organic pathology) |
Mots-clés : |
Thésaurus mots-clés BUPRENORPHINE ; MESUSAGE ; INJECTION ; NECROSE ; ABCES ; PEAU ; GREFFE |
Résumé : | In May 2002 Buprenorphine (Subutex) was listed on the Australian Pharmaceutical Benefits Schedule for treatment in opioid dependence. In addition to broadening treatment options, buprenorphine has the advantage of an improved safety profile. The risk of overdose is lessened but other risks remain due to diversion. French experience reports widespread deviation of buprenorphine sublingual tablets to intravenous injection. We report a case of attempted parenteral administration of buprenorphine tablets. Stringent protocols for dispensing are appropriate. (Review's abstract.) |
Domaine : | Drogues illicites / Illicit drugs |
Refs biblio. : | 11 |
Affiliation : |
Alcohol Drug Ass. Unit, Princ. Alexandra Hosp., Ipswich R., Woolloongabba, Brisbane, QLD. Australie. Australia. |
Numéro Toxibase : | 804503 |
Centre Emetteur : | 08 CAS Strasbourg |
Accueil